أرسل هذا في رسالة قصيرة: Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

__    __     ___      _____     ______    _____   
\ \\ / //   / _ \\   /  ___||  /_   _//  / ____|| 
 \ \/ //   | / \ || | // __     -| ||-  / //---`' 
  \  //    | \_/ || | \\_\ ||   _| ||_  \ \\___   
   \//      \___//   \____//   /_____//  \_____|| 
    `       `---`     `---`    `-----`    `----`